Newer schizophrenia drug isn’t necessarily better

By Science News Staff, 14:33 PM May 20, 2014

Guest post by Laura Sanders

An injectable form of a newer, more expensive schizophrenia drug works no better than an older drug, scientists report May 21 in the Journal of the American Medical Association. In a randomized clinical trial of 311 people with schizophrenia, injections of paliperidone palmitate failed to alleviate schizophrenia symptoms just as often as did injections of haloperidol decanoate, a drug that’s been around for decades.

A single injection of paliperidone palmitate, a sec...

Source URL:’t-necessarily-better